W2P, I was struck by the following paragraph in the Moffit/IBM piece:
"The project will provide an integrated research platform to focus on the identification of specific molecular and genetic markers that will predict the risk level of developing lung cancer, response to treatment, as well as the ultimate patient outcome. Building upon this model, Moffitt and IBM will work together to incorporate other cancer data, including myeloma and breast cancer. Additionally, other research, including functional genomics, proteomics, gene expression analyses, drug discovery and cell therapies, will be integrated into the system in later stages."
Certainly looks to be some potential synergy there to me (but then again my glass is half full lol).
News 
Market Data 
Discover 
